Skip to main content
. 2014 Dec 10;3:e04037. doi: 10.7554/eLife.04037
KHM-3S cells pEGFR pAKT pERK pMET
Control 1 1 1 1
Erlotinib alone 0.008 0.609 0.18 1.098
Erlotinib + HGF 0.014 1.381 0.979 11.66
Erlotinib + HGF + Crizotinib 0.023 0.417 0.085 1.095

• HGF activates pMET and pERK in the presence of Erlotinib.

• Crizotinib blocks HGF-induced pMET and pERK activation.